SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Barbara Bullard who wrote (53597)7/29/1999 2:36:00 AM
From: Jenna  Read Replies (2) of 120523
 
MLNM.. i'm not too sure because I was away after the morning buys. I have hired a wonderful researcher in this sector and she keeps me informed. Lexicon Genetics Announces Agreement With Millennium Pharmaceuticals
Marks Lexicon's 9th Corporate Collaboration for Knockout Mouse Creation
THE WOODLANDS, Texas, July 27 /PRNewswire/ -- Lexicon Genetics Incorporated announced today the signing of a multi-year agreement with Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM - news). Under the agreement, Lexicon will use its portfolio of proprietary homologous recombination technologies to create genetically-engineered mice for use by Millennium in the validation of potential drug targets identified and selected by Millennium.

also on he 26th coveage was initiated by Prudential and a split seems imminent. THis one is not really a daytrade, but it is nOT a stock to hold without careful following.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext